Back

Is bivalirudin just an expensive heparin?

European Heart Journal

22 February 2016
Organised by: Logo
Read full article
ESC Journals

Contributors

Petr Widimský
Petr Widimský

Author

You may be interested in
thumbnail
Congress Presentation
Anticoagulation management of heartware left ventricular assist device thrombosis: comparison of heparin and bivalirudin
3 September 2019
thumbnail
Congress Presentation
Budget impact analysis of antiplatelet therapy with cangrelor in patients with acute coronary artery disease undergoing percutaneous coronary intervention in Belgium
13 March 2021
thumbnail
Congress Presentation
Mortality with bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome
28 August 2023
thumbnail
Congress Presentation
Is there an inter-manufacturer difference in generic clopidogrel response?
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources